The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Senescent cells: an emerging target for diseases of ageing
Open accessAbstract
Chronological age represents the single greatest risk factor for human disease. One plausible explanation for this correlation is that mechanisms that drive ageing might also promote age-related diseases. Cellular senescence, which is a permanent state of cell cycle arrest induced by cellular stress, has recently emerged as a fundamental ageing mechanism that also contributes to diseases of late life, including cancer, atherosclerosis and osteoarthritis. Therapeutic strategies that safely interfere with the detrimental effects of cellular senescence, such as the selective elimination of senescent cells (SNCs) or the disruption of the SNC secretome, are gaining significant attention, with several programmes now nearing human clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In cancer, the SASP can frequently promote therapy resistance and recurrence [34].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [34]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While senescence has beneficial functions (such as tumor suppression), senescent cells accumulate in most tissues with age, and they are important components of the overall aging process62.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several senolytic drugs, such as ABT‐737, BET inhibitors and dasatinib plus quercetin, can selectively induce cell death in senescent cells and effectively improve some symptoms of age‐related disease, including cancer, by attenuating SASP factor production.81”
From Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer (2020) · cites this paper as [81]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The literature is becoming inundated with evidence that senescent cells accumulate in a variety of age-associated diseases13.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [13]
In the citing paper
“In particular, this failsafe cellular senescence reportedly occurs in response to (1) potentially carcinogenic events including oncogene activation or oncosuppressor gene inactivation; and (2) several sublethal cellular insults, including telomere shortening, DNA damage, mitochondrial dysfunction, defective/stalled DNA replication and epigenetic, lysosomal, mechanical, metabolic, mitotic, ox”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [958]
In the citing paper
“Genetic and pharmacological strategies have demonstrated the benefits of eliminating senescent cells in the context of aging and disease 10,12,51.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [51]
In the citing paper
“Organismal aging and age-related diseases promote an accumulation of senescent cells in a variety of tissues in both humans and mice (8).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [8]
In the citing paper
“Senescent cells are more than simple bystanders, as multiple molecules involved in the SASP act as promoters of atherosclerosis and are biomarkers of CVD risk.23”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [23]
In the citing paper
“Small molecules that can selectively kill SCs, termed senolytics, have the potential to prevent and treat a growing number of age-related diseases and extend healthspan2–4.”
From Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity (2020) · cites this paper as [2]
In the citing paper
“SCs accumulate with age and as a result of the exposure to a variety of stressors including radiation.”
From Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity (2020) · cites this paper as [2]
In the citing paper
“By contrast, almost all the targeted senolytics are repurposed anticancer agents except the FOXO4-p53 interfering peptide2–4.”
From Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity (2020) · cites this paper as [2]
In the citing paper
“They play a causal role in many age-related diseases (such as neurodegenerative and cardiovascular diseases, osteoarthritis, and cancer) via expression of the senescence-associated secretory phenotype (SASP) to secret various inflammatory mediators and proteases1–7.”
From Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity (2020) · cites this paper as [2]
In the citing paper
“Our studies also confirm some of the previous observations that SCs from different cellular origins and tissues show variable sensitivities to different senolytic agents2–5.”
From Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity (2020) · cites this paper as [2]
In the citing paper
“This observation is in agreement with the suggestion that different SCs can use different anti-apoptotic pathways (SCAPs) to resist apoptosis2–5.”
From Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity (2020) · cites this paper as [2]
In the citing paper
“Cell senescence occurs throughout the lifespan but plays a larger role with aging and is postulated to contribute to many diseases of aging including vascular disease, arthritis, and neurodegeneration. 38”
From Alzheimer’s disease drug development pipeline: 2021 (2021) · cites this paper as [38]
In the citing paper
“Excessive accumulation of senescent cells in numerous tissues leads to multiple chronic diseases, tissue dysfunction, age-related diseases and organ ageing.”
From Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases (2020) · cites this paper as [14]
In the citing paper
“However, excessive accumulation of senescent cells causally shortens the healthy lifespan [11] and drives organ ageing [12], age-related organ deterioration/disorders [13,14], tissue dysfunction and chronic diseases, including cardiovascular diseases (CVDs) [15,16], cancer [2], neurodegenerative diseases [17,18] and osteoarthritis [19].”
From Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases (2020) · cites this paper as [14]
In the citing paper
“However, the senolytic drugs identified to date were not discovered by a truly unbiased high-throughput screening (HTS) method, and thus appear to have limitations in clinical applications15,17–19.”
From A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells (2020) · cites this paper as [15]
In the citing paper
“the combination of dasatinib and quercetin (D + Q), another previously reported senolytic drug20, apparently exhibited remarkable cell-type specificity15”
From A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells (2020) · cites this paper as [15]
In the citing paper
“in a phase II study of ABT263 (a specific inhibitor of the anti-apoptotic proteins BCL2 and BCL-xL)19 for the treatment of advanced and recurrent small-cell lung carcinoma patients, transient thrombocytopenia and neutropenia were reported as side-effects15.”
From A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells (2020) · cites this paper as [15]
In the citing paper
“Cellular senescence impairs the ability of tissue regeneration and drives chronic low-grade inflammation, which exacerbates the aging process.5,6”
From Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice (2020) · cites this paper as [6]
In the citing paper
“Cellular senescence impairs the ability of tissue regeneration and drives chronic low-grade inflammation, which exacerbates the aging process.5,6”
From Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice (2020) · cites this paper as [6]
In the citing paper
“These studies demonstrated that senescence is one of the major drivers of aging and that clearing senescent cells is a promising approach to treat age-related diseases and improve physical function.6,10”
From Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice (2020) · cites this paper as [6]
In the citing paper
“However, senolytic drugs have significant limitations in killing senescent cells in terms of specificity and broad-spectrum activity because of the dynamic and highly heterogeneous nature of the senescence program, which leads to the varying sensitivity of different types of senescent cells to current senolytic drugs.6,16,17”
From Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice (2020) · cites this paper as [6]
In the citing paper
“SASP contributes to local and systemic low-grade inflammation during aging, to age-related degenerative phenotypes, and to impairment of physical function.5,6,43”
From Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice (2020) · cites this paper as [6]
In the citing paper
“Senescent cells produce a distinct inflammatory secretome and have been found to accumulate with age and in many diseases; potentially contributing to pathology [17–21].”
From Untangling senescent and damage‐associated microglia in the aging and diseased brain (2023) · cites this paper as [17]
In the citing paper
“Senescent cells produce a distinct inflammatory secretome and have been found to accumulate with age and in many diseases; potentially contributing to pathology [17–21].”
From Untangling senescent and damage‐associated microglia in the aging and diseased brain (2023) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H. K., Deyo, R. A., Gabriel, S. E., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,599
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Self-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T. I., Hudson, M. M., Meadows, A. T., Friedman, D. L., Marina, N. M., Hobbie, W. L., Kadan‐Lottick, N. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa060185 · Cited by 3,597
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
Flagged first, then by citations
Research works printed but not linked: 1
- Weismann, A. Collected Essays upon Heredity and Kindred Biological Problems (ed. Poulton, E. B.) (Clarendon, 1881).
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Xu, Z., Su, P., Zhou, X., Zheng, Z., Zhu, Y., & Wang, Q. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1422306 · Cited by 4
Inflammatory aging. Part 1. The principal biochemical mechanisms
Metelskaya, V. A., Timofeev, Y. S., Neshkova, E. A., Dubovskaya, N. I., & Drapkina, O. M. (2024) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202427121145 · Cited by 4
Natural Product-Derived Senotherapeutics: Extraction and Biological Evaluation Techniques
Pratsinis, H., Mavrogonatou, E., Zervou, S., Triantis, T. M., Hiskia, A. E., & Kletsas, D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4426-3_19 · Cited by 4
NOMA-DB: a framework for management and analysis of ageing-related gene-expression data
Guzzi, P. H., Lomoio, U., Scicchitano, R., & Veltri, P. (2022) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm55620.2022.9994891 · Cited by 4
Modified Peptide Molecules As Potential Modulators of Shelterin Protein Functions; TRF1
Brankiewicz, W., Kalathiya, U., Padariya, M., Wegrzyn, K. E., Prusinowski, M., Żebrowska, J., Żylicz-Stachula, A., Skowron, P. M., Dráb, M., Szajewski, M., et al. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202300970 · Cited by 4
Rui, H., Yu, H., Zou, D., Chi, K., Xu, P., Song, X., Liu, L., Wu, X., Wang, J., & Xue, L. (2023) · Emergency and Critical Care Medicine · doi:10.1097/ec9.0000000000000097 · Cited by 4
Tsai, Y., González, E. A., Grodzki, A. C., Bruun, D. A., Saito, N. H., Harvey, D. J., & Lein, P. J. (2024) · Frontiers in Toxicology · doi:10.3389/ftox.2024.1360359 · Cited by 4
Almeida, M., & Manolagas, S. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00012-9 · Cited by 4
Novel Probes and Carriers to Target Senescent Cells
Lozano‐Torres, B., Blandez, J. F., Sancenón, F., & Martínez‐Máñez, R. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_9 · Cited by 4
Activités physiques, sédentarité, comorbidités et arthrose
Fouquet, B., & Jaume-Guichard, P. (2021) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2021.03.005 · Cited by 4
Nutrition senolytics - illusion or reality for cognitive ageing?
Chen, X., Brodaty, H., & O’Leary, F. (2021) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000796 · Cited by 4
Generation of mice for evaluating endogenous p16Ink4a protein expression
Shimada-Takayama, Y., Yasuda, T., Ukai, T., Taguchi, J., Ozawa, M., Sankoda, N., Ohta, S., & Yamada, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.02.005 · Cited by 4
Mu, H., Gao, Y., Cao, G.-C., Jiang, J., Wang, H., & Zhao, W. (2022) · Fitoterapia · doi:10.1016/j.fitote.2022.105165 · Cited by 4
Xia, Y., Li, J., Wang, L., Xie, Y., Zhang, L., Han, X., Tan, W., & Liu, Y. (2022) · Angewandte Chemie · doi:10.1002/ange.202214169 · Cited by 4
Sharma, G., Pund, S., Govindan, R., Nissa, M. U., Biswas, D., Middha, S., Ganguly, K., Mahesh, P. A., Banerjee, R., & Srivastava, S. (2023) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2023.0074 · Cited by 4
Chimeric Antigen Receptor T Cells as Senolytic and Antifibrotic Therapy
Ravichandra, A., Filliol, A. A., & Schwabe, R. F. (2020) · Hepatology · doi:10.1002/hep.31596 · Cited by 4
Gene therapy for p16-overexpressing cells
Demaria, M. (2018) · Aging · doi:10.18632/aging.101422 · Cited by 4
Anthracycline cardiotoxicity: looking for new therapeutic approaches targeting cell senescence?
Abid, S., Lipskaia, L., & Adnot, S. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy108 · Cited by 4
Senescence diversity in muscle aging
Durik, M., & Keyes, W. M. (2022) · Nature Aging · doi:10.1038/s43587-022-00255-3 · Cited by 4
Zhou, W., Yu, C., Meng, T., Jiang, Q., Yu, F., & Yuan, H. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125469 · Cited by 3
Revealing the Landscape Crosstalk Between Reproductive System and Organs Aging
Wu, J., Wu, P., Wang, S., Guan, Y., & Wang, J. (2025) · The FASEB Journal · doi:10.1096/fj.202403410r · Cited by 3
Zeng, J., Yang, T., Gao, Y., Shen, Y., Li, S., Zhang, H., Zhou, J., Cheng, D., & He, L. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c07050 · Cited by 3
Sha, Z., Ma, Y., Li, W., Cao, Y., He, Z., Zheng, L., Lv, H., Zhou, X., He, C., & Zhu, R. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202502365 · Cited by 4
Monyatovsky, H., Anderson, T., & Nadeau, J. (2025) · ACS Omega · doi:10.1021/acsomega.5c07583 · Cited by 3
Tang, J.-Z., Feng, L. P., Liu, T., & Sun, X.-Z. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.11.005 · Cited by 3
Liu, S., Chen, W., Xu, G., Liu, X., Shi, Y., Wang, G., Ning, Y., Cao, Y., Li, M., & Zhao, Y. (2026) · Chinese Medicine · doi:10.1186/s13020-025-01319-3 · Cited by 3
Epididymal macrophage senescence contributes to sperm motility decrease upon environmental stress
Wang, X.-R., Li, H., Xiong, Y.-W., Yuan, Z., Cheng, X.-Y., Hu, Y., He, X., Fan, L.-L., Luo, Y., Sun, J., et al. (2026) · Science Advances · doi:10.1126/sciadv.aea3591 · Cited by 3
Communication breakdown: senescent cells in interorgan communication of aging
Ghosh, R. B., Dipali, S. S., Desdín-Micó, G., & Yousefzadeh, M. J. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.02.002 · Cited by 3
da Rosa, S. A., Oliveira, H. M., de Mendonça, L. B., de Oliveira, N. B., Jaeger, M. D. C., Pereira, L. C., Oliveira, F. D., Santos‐Sousa, D., Saez‐Calazans, F., Lenz, L. S., et al. (2026) · Aging Cell · doi:10.1111/acel.70477 · Cited by 3
Qiao, Y., Zhao, J., Liu, M., Liu, J., Qiao, Z., Xu, R., Ning, X., Sun, S., & Chen, X. (2026) · Biomolecules · doi:10.3390/biom16040611 · Cited by 3
YAP upregulates AMPKα1 to induce cancer cell senescence
Zhan, Y., Wu, G., Fan, X., Fu, Z., Ni, Y., Sun, B., Chen, H., Chen, T., & Wang, X. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106559 · Cited by 3
A precise dual-drug codelivery nanosystem for treating kidney failure by eliminating senescent cells
Jin, S., Li, W., Huang, Q., Zeng, X., & Zhang, X. (2024) · Science China Materials · doi:10.1007/s40843-024-2864-5 · Cited by 3
Lin, H., Yao, T., Ding, H., Chu, J., Yuan, D., Fan, P., Chen, F., & Liu, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37028 · Cited by 3
Wan, L., Yu, M., Duan, Y., Wu, Q., Liu, H., Shen, S., Wang, X., Shi, C., Liao, X., & Zheng, H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113838 · Cited by 3
PM2.5 exposure reprograms cell cycle dynamics in uterine immune cells at single-cell resolution
Zhang, L., Tian, J., Zheng, Y., & Duan, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1561290 · Cited by 3
Yang, J., Zhong, J., Du, Y., Liu, J., Li, Z., & Liu, Y. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112811 · Cited by 4
E2F1 inhibits cellular senescence and promotes oxaliplatin resistance in colorectal cancer
Gao, H., Zhou, F., Li, R., Yuan, J., & Ye, L. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-4054 · Cited by 3
Identification of novel inhibitors of the transcriptional coactivator MRTF-A for HCC therapy
Franz, M. J., Wenisch, P., Wohlleben, P., Rupprecht, L., Chubanov, V., Gudermann, T. W., Kyheröinen, S., Vartiainen, M. K., Heinrich, M. R., & Muehlich, S. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200855 · Cited by 3
Qi, Q., Pang, J., Chen, Y., Tang, Y., Wang, H., Gul, S., Sun, Y., Tang, W., & Sheng, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011232 · Cited by 3
Gomez, L. S., & Jurk, D. (2024) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-66768-8_5 · Cited by 3
Molecular Biomarkers of Health
Nehlin, J. O., & Andersen, O. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-52663-4_15 · Cited by 3
Gerosuppressive and Senolytic Nutrients
Nehlin, J. O. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-83017-5_22 · Cited by 3
Healthy aging—would cytotoxic T lymphocytes stand out?
Zhang, T., Zhang, J., & Wang, S. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01699-1 · Cited by 3
Mechanisms underlying retardation of aging by dietary energy restriction
Shimokawa, I. (2023) · Pathology International · doi:10.1111/pin.13387 · Cited by 3
Proceedings of the inaugural Dark Genome Symposium: November 2022
Boeke, J. D., Burns, K. H., Chiappinelli, K. B., Classon, M., Coffin, J. M., DeCarvalho, D., Dukes, J. D., Greenbaum, B. D., Kassiotis, G., Knutson, S. K., et al. (2023) · Mobile DNA · doi:10.1186/s13100-023-00306-5 · Cited by 3
Durik, M., Karout, M., Gonçalves, D. S., Knauer-Meyer, T., Spiegelhalter, C., Messaddeq, N., Seehawer, M., Stephan, P., Bulavin, D. V., Hérault, Y., et al. (2026) · Developmental Cell · doi:10.1016/j.devcel.2026.08.002 · Cited by 3
Cellular Senescence and Tumor Promotion
Demaria, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_79 · Cited by 3
Polyphenols as Modulators of Oxidative Stress in Cancer Disease
Yadav, E., Yadav, P. S., Kamal, M. A., & Verma, A. (2021) · Springer eBooks · doi:10.1007/978-981-16-4935-6_5 · Cited by 3
Kamat, A., & Katz, M. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11448-5 · Cited by 3
Lio, R. M. S., Maugeri, A., Rosa, M. C. L., Giunta, G., Panella, M. M., Cianci, A., Caruso, M. A. T., Agodi, A., & Barchitta, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-15370-9 · Cited by 3
Wu, G., Li, X., Zhan, Y., Fan, X., Xu, L., Chen, T., & Wang, X. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.023 · Cited by 3
Picallos-Rabina, P., Silva‐Álvarez, S. D., Antelo-Iglesias, L., Triana-Martínez, F., & Collado, M. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_5 · Cited by 3
Ávila, J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240500 · Cited by 3
Salnikov, L., Goldberg, S. I., & Pinsky, E. (2023) · Medical Research Archives · doi:10.18103/mra.v12i1.4927 · Cited by 2
Liu, X., Li, B., Liu, S., Zong, J., & Zheng, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34766 · Cited by 2
Cellular senescence and senotherapeutics in cardiovascular diseases
Pal, A. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.01.019 · Cited by 2
MicroRNA‐34a Mediates the Aldosterone‐Induced Acceleration of Endothelial Senescence
Jia, M., Lin, L., Yang, B., Yu, H., Zhong, S., Xu, X., & Song, X. (2025) · International Journal of Hypertension · doi:10.1155/ijhy/2339598 · Cited by 2
Yao, L., Li, F., Ni, J., Wei, M., Li, T., Shi, J., & Tian, J. (2025) · Aging Medicine · doi:10.1002/agm2.70031 · Cited by 3
Lambert, M., Miquel, G., Cagnone, G., Mury, P., Villeneuve, L. R., Lesage, F., Thorin‐Trescases, N., & Thorin, É. (2025) · GeroScience · doi:10.1007/s11357-025-01763-x · Cited by 2
Osteoblast‐CD4 + CTL Crosstalk Mediated by SIRT1/DAAM2 Axis Prevents Age‐Related Bone Loss
Yang, B., Zhang, G., Zhu, Y., Wang, J., Feng, X., Fei, W., Dai, J., Hu, L., Zhang, Y., Cai, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202501170 · Cited by 3
Guo, X., Zhang, S., Sun, Q., Li, H., & Wang, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1627412 · Cited by 2
Immunosenescence and Ageing: An Entangled Web of Senescence and Declining Immunity
Ahmed, A. U. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl42709 · Cited by 2
Jurcău, M. C., Iovanovici, D. C., Jurcău, A., Militaru, M., Udrea, R. B., Comanescu, A. D., & Nunkoo, V. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189009 · Cited by 2
Jang, J.-H., & Jang, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189218 · Cited by 2
ANTI-AGING DRUGS: A COMPREHENSIVE PHARMACOLOGICAL ANALYSIS
TIWARI, S. N., Baheti, T. C., Rajesh, C., & SHARMA, R. K. (2025) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2025v17i5.7047 · Cited by 2
Feng, R., Aihaiti, Y., Yu, H., Xu, K., Lu, C., & Xu, P. (2025) · Clinical Rheumatology · doi:10.1007/s10067-025-07669-5 · Cited by 2
Arora, S., Halsey, G., Zohora, F. T., Swiss, A., & Vyavahare, N. R. (2025) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320251391142 · Cited by 2
Wang, P., Zhao, H., Zhang, S., Guo, Y., Xing, X., Zhou, S., Yang, S., Wang, F., Chen, W., Wang, J., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.11.038 · Cited by 2
Cancer therapy-related cardiovascular aging: mechanisms, monitoring, and intervention strategies
Lin, X., Wu, Z., Liu, Y., & Liao, X. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1668623 · Cited by 2
Hu, J., Mao, T., Huang, K., Yang, S., Yu, W., Huang, J., Jin, S., Sun, C., Jiapaer, Z., & Wang, X. (2026) · Cell Cycle · doi:10.1080/15384101.2025.2611968 · Cited by 3
Cellular Senescence in the Ascending Aorta and Complexity of Coronary Atherosclerosis
Abanus, H., Vural, M., Katkat, F., Paşaoğlu, E., Olgun, A., & Mert, B. (2026) · Journal of Aging Research · doi:10.1155/jare/9142131 · Cited by 2
Meng, B., Li, X., Yang, B., Qu, Y., He, Y., Fu, C., An, Z., Wu, A., Hei, Y., Zhang, R., et al. (2026) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70224 · Cited by 2
Liu, Y., Ai, J., Zhang, Z., Lu, X., Yu, C., Zha, Y., & Zhang, H. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71018 · Cited by 2
Lung mTOR activation leads to lung fibrosis or emphysema via senescence of specific lung cells
Houssaini, A., Marcos, É., Gros, V., Born, E., Abid, S., Rideau, D., Beaulieu, D., Jacquet, J., Lipskaia, L., Gökyildirim, M. Y., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-43628-z · Cited by 3
Senescent Factors Suppress Innate Antiviral Immunity in Aged Mice via Two Distinct Mechanisms
Zhang, X., Zhang, Q., Wang, L., Li, S., & Shu, H. (2026) · Aging Cell · doi:10.1111/acel.70471 · Cited by 2
Cellular senescence: from pathogenic mechanisms to precision anti-aging interventions
Deng, J., Sun, R., Bai, Z., Fang, L., Zhao, X., & Yang, D. (2026) · Aging · doi:10.18632/aging.206375 · Cited by 2
Targeting Age-Associated Immune Senescence via Nanoparticle-Based Metabolic Reprogramming
Nair, P. G., Unnikrishnan, B. S., Vijayan, V. V., Howlett, S. E., Cullis, P. R., & Gujar, S. A. (2026) · ACS Nano · doi:10.1021/acsnano.5c18638 · Cited by 2
Cellular senescence as a systems-level driver of cardiovascular ageing
Wang, M.-M., Liu, T., Xu, C.-Q., Zhong, Y.-L., Liang, Z.-Q., Li, J., Cao, Y., & Chen, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103175 · Cited by 2
Liu, Y., Liang, S., Bu, F., Wu, P., Zhou, X., Zhao, J., Shen, M., Wei, M., Yang, G., & Yuan, L. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04555-3 · Cited by 2
Quercetin Mitigates Oxidative Stress-Induced Premature Senescence in SH-SY5Y Neuronal-like Cells
Salamone, F. L., Molonia, M. S., Trischitta, S., Saija, A., Cimino, F., & Speciale, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135759 · Cited by 2
Bi, J., Zeng, J., Liu, X., Mo, C., Yao, M., Zhang, J., Yuan, P., Jia, B., & Xu, S. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102209 · Cited by 2
Li, Y., Lin, Y., Chen, Z., Ji, W., & Liu, H. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111579 · Cited by 2
BET family protein degraders poised to join the senolytic arsenal
Guo, Z., Peng, H., & Xie, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0202-2 · Cited by 2
-, E. D., & -, D. D. P. (2024) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2024.v06i03.22349 · Cited by 2
Peng, X., Zhong, Y., Mao, R., He, F., Cheng, Y., Chen, M., Zhou, L., Xie, H., Li, J., & Zhang, Y. (2024) · Experimental Dermatology · doi:10.1111/exd.15120 · Cited by 2
Hu, J., Yang, F., Yang, G., Pan, J., Tan, Y., Tang, Y., Liu, Y., Zhang, H., & Wang, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1361284 · Cited by 2
Yan, Q., Zhang, H., Ma, Y., Sun, L., Chen, Z., Zhang, Y., & Guo, W. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.029 · Cited by 2
Walewska, E., Hamada, Z., Pérez-García, V., & Galvão, A. M. (2024) · Reproduction · doi:10.1530/rep-24-0319 · Cited by 2
Sessions, G. A., Loops, M. V., Diekman, B. O., & Purvis, J. E. (2025) · GeroScience · doi:10.1007/s11357-024-01503-7 · Cited by 2
Platelet Immune Interactions, Lifespan, and Senescence
Nydegger, U. E., & Imbach, P. A. (2025) · OBM Geriatrics · doi:10.21926/obm.geriatr.2501297 · Cited by 2
Haitao, L. I. U., Gong, Y., Nakagawa, M., Tanimoto, H., Yoshikawa, K., Honda, Y., & Yamamoto, K. (2023) · Dental Materials Journal · doi:10.4012/dmj.2022-245 · Cited by 2
Epitranscriptomics: new players in an old game
Coego, A., Molares, H. C., & Guallar, D. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221417 · Cited by 2
Selected phenolic compounds in the modulation of biochemical pathways involved in aging
Spagnuolo, L., Lelli, D., Lattanzi, G., Dugo, L., Pedone, C., & Gara, L. D. (2023) · Redox Experimental Medicine · doi:10.1530/rem-23-0017 · Cited by 2
Macrophage migration inhibitory factor reversed senescent phenotype in human chondrocytes in vitro
Fu, Z., Li, Q., Jiang, P., Song, X., Yang, J., Chen, G., Gong, X., & Yang, L. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09101-0 · Cited by 2
DRUGS WITH SENOLYTIC ACTIVITY: PROSPECTS AND POSSIBLE LIMITATIONS
Васильевна, М. Г., & Khokhlov, A. N. (2024) · Vestnik Moskovskogo universiteta Seria 16 Biologia · doi:10.55959/msu0137-0952-16-78-4-3 · Cited by 2
Drugs with Senolytic Activity: Prospects and Possible Limitations
Васильевна, М. Г., & Khokhlov, A. N. (2023) · Moscow University Biological Sciences Bulletin · doi:10.3103/s0096392524600455 · Cited by 2
Rinnerthaler, M., & Richter, K. (2018) · InTech eBooks · doi:10.5772/intechopen.76246 · Cited by 2
Čepelak, I., & Dodig, S. (2019) · Rad Hrvatske akademije znanosti i umjetnosti Medicinske znanosti · doi:10.21857/moxpjhglzm · Cited by 2
Phenotypic Personhood: Epigenetics and the Biolegality of Processing Asylum
Ihar, Z. D. (2019) · Springer eBooks · doi:10.1007/978-3-030-27848-9_8 · Cited by 3
Interconnection Between Cellular Senescence, Regeneration and Ageing in Salamanders
Yu, Q., & Yun, M. H. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_3 · Cited by 2
Metadata
- Authors
- Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Unity Biotechnology (United States) (US)
- Venue
- Nature Reviews Drug Discovery
- Published
- 2017-07-21
- Volume
- 16
- Issue
- 10
- Pages
- 718-735
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC5942225
- OpenAlex
- W2739438570
- Cited by
- 1,284
- References
- 216
- Citations by year
- 2026: 146 · 2025: 157 · 2024: 166 · 2023: 162 · 2022: 149 · 2021: 168 · 2020: 146 · 2019: 108 · 2018: 73 · 2017: 8
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (T32AG049672)
- National Cancer Institute (R01CA168709, R01CA096985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, senescent cells, aging, age-related diseases, cancer, atherosclerosis, osteoarthritis, senolytics, senescence-associated secretory phenotype, cell cycle arrest, cellular stress, senolytic therapy
- MeSH terms
- Aging, Animals, Humans, Neoplasms, Cellular Senescence, Cell Proliferation, Atherosclerosis, Cell Cycle Checkpoints
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
